Lv32
380 积分 2025-05-28 加入
Chronic obstructive pulmonary disease
5天前
已完结
Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition
17天前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
18天前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
18天前
已完结
Novel anti-HER2 nanobody-drug conjugates with enhanced penetration of solid tumor and BBB, reduced systemic exposure and superior antitumor efficacy
18天前
已完结
Antibody-drug conjugates in breast cancer: From therapeutic and immune activation mechanisms to resistance prevention
18天前
已完结
Blood Pressure Control, Proteinuria, and the Progression of Renal Disease
26天前
已完结
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors
27天前
已完结
Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation
27天前
已完结
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
27天前
已完结
皖公网安备34019202002308
